V.V. KOMOK, S.A. BELYY, O.A. GRINENKO, A.S. NEMKOV

First Saint Petersburg State Medical University named after acad. I.P. Pavlov of the Ministry of Health of the Russian Federation, 6-8 Lev Tolstoy St., St. Petersburg, Russian Federation, 197022

Komok V.V. — postgraduate student of the Department of departmental surgery, tel. +7-904-632-19-00, e-mail: vladimir_komok@mail.ru

Belyy S.A. — Cand. Med. Sc., Head of the Laboratory of Cardiac Surgery of research and development centre, tel. +7-921-758-44-95, e-mail: sabel1968@mail.ru

Grinenko O.A. — D. Med. Sc., pro-rector of clinical work, tel. +7-921-913-91-71, e-mail: grinenko77@mail.ru

Nemkov A.S. — D. Med. Sc., Professor of the Department of faculty surgery, tel. +7-921-795-00-47, e-mail: nemk_as@mail.ru

Treatment of ischemic heart disease is an urgent problem until now. Despite advances in modern medicine, there is a fairly large group of patients for whom the use of just the drugs and / or surgical techniques fails to improve the quality of life. In this article there is an overview of clinical trials, which served as a prerequisite for further clinical and experimental study of cellular technology in treatment of ischemic heart disease.

Key words: ischemic heart disease, myocardial infarction, coronary artery bypass surgery, autologous bone marrow mononuclear cells.

REFERENCES

1. WHO Global InfoBase, available at: http:www.infobase.who.int
2. Oganov R.G., Kontsevaya A.V., Kalinina A.M. The economic costs of cardiovascular diseases in the Russian Federation. Kardiovaskulyarnaya terapiya i profilaktika, 2011, no. 10 (4), pp. 4-9 (in Russ.).
3. Carrel A. On experimental surgery of thoracic aorta and the heart. Ann Surg, 1910, vol. 52, rr. 83-95.
4. Kersten J.R., Pagel P.S., Chilian W.M. et al. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc. Res, 1999, vol. 43, pp. 44-57.
5. Campeau L., Enjalbert M., Lesperance J. et al. The relation of risk factor to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Engl J Med, 1984, vol. 311, rr. 1329-1332.
6. Fitzgibbon G.M., Kafka H.P., Leach A.J. et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol, 1996, vol. 28, rr. 616-626.
7. Griffith L.S., Achuff S.C., Conti C.R. et al. Changes in intrinsic coronary circulation and segmental ventricular motion after saphenous-vein coronary bypass graft surgery. N Engl J Med, 1973, Mar 22, vol. 288 (12), rr. 589-95.
8. Kur’yanov P.S., Razuvaev A.S., Vavilov V.N. Intimal hyperplasia in the area of ​​vascular anastomosis. Angiologiya i sosudistaya khirurgiya, 2008, vol. 14. no. 4, pp. 146-147 (in Russ.).
9. Belenkov Yu.N., Privalov E.V., Chekneva I.S. Cell therapy of chronic heart failure: types of stem cells used, the results of recent clinical studies. Kardiol serdečno-sosud hir, 2008, 5, rr. 4-18 (in Russ.).
10. Dohmann H.F., Perin E.C., Takiya C.M. et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohis-tochemical findings. Circulation, 2005, vol. 112 (4), rr. 521-526.
11. Orlic D., Kajstura J., Chimenti S. et al. Bone marrow cells regenerate infarcted myocardium. Nature, 2001, vol. 410, rr. 701-5.
12. Anversa P., Leri A. Kajstura J. Cardiac regeneration. J Am Coll Cardiol, 2006, vol. 47, rr. 1769-76.
13. Alvares-Dolado M., Pardal R., Garcia-Verdugo J.M. et al. Fusion of bone marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 2003, vol. 425, rr. 968-73.
14. Terada N., Hamazaki T., Oka M. et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature, 2002, vol. 416, rr. 542-5.
15. Hamano K., Nishida M., Hirata K. et.al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J, 2001, Sep, vol. 65 (9), rr. 845-7.
16. Strauer B.E., Brehm M., Zeus T. et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 2002, vol. 106, rr. 1913-8.
17. Assmus B., Schachinger V., Teupe C. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 2002, vol. 106, rr. 3009-17.
18. Wollert K.C., Meyer G.P., Lotz J. et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 2004, vol. 64, rr. 141-8.
19. Dubois C., Liu X., Claus P. et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol, 2010, vol. 55, rr. 2232-43.
20. Kaminski A., Steinhoff G. Current status of intramyocardial bone marrow stem cell transplantation. Semin Thorac Cardiovasc Surg, 2008, vol. 20, rr. 119-25.
21. Zhao Q., Sun Y., Xia L., Chen A., Wang Z. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg, 2008, vol. 86, rr. 1833-40.
22. Patel A.N., Geffner L., Vina R.F. et al. Surgical treatment for congestive heart failure with autologous stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg, 2005, vol. 130, rr. 1631-9.
23. Nemkov A.S., Belyy S.A., Nesteruk Yu.A., Burnos S.N., Lukashenko V.I., Kreyl’ V.A., Kobak A.E., Ryzhkova D.V., Yudina O.V. Quality of life in patients with coronary heart disease after application of cell therapy. Vestnik khirurgii, 2012, no. 171 (1), pp. 16-20 (in Russ.).
24. Gowdak L.H., Schettert I.T., Rochitte C.E. et al. Early increase in myocardiperfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery. J Cardiovasc Transl Res, 2011, vol. 4, rr. 106-13.
25. Nasseri B.A., Kukucka M., Dandel M. et al. Two-dimensional speckle tracking strain analysis for efficacy assessment of myocardial cell therapy. Cell Transplant, 2009, vol. 18, rr. 361-70.
26. Hendrikx M., Hensen K., Clijsters C. et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation, 2006, vol. 114, rr. I101-7.
27. Ang K.L., Chin D., Leyva F. et al. Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med, 2008, vol. 5, rr. 663-70.
28. Yoo K-J., Kim H-O., Kwak Y-L. et al. Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy. Can J Surg, 2008, vol. 51 (4), rr. 269-75.
29. Stamm C., Kleine H.D., Choi Y.H. et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg, 2007, vol. 133, rr. 717-25.
30. Patel A.N., Geffner L., Vina R.F. et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg, 2005, vol. 130, rr. 1631-8.
31. Donndorf P., Kundt G., Kaminski A. et al. Intramyocardial bone marrow stem cell transplantation duringcoronary artery bypass surgery: A meta-analysis. The Journal of Thoracic and Cardiovascular Surgery, vol. 142, no. 4.
32. Van Ramshorst J., Bax J.J., Beeres S.L. et al. Intramyocardial bone marrow cell for chronic myocardial ischemia. A randomized controlled trial. JAMA, 2009, vol. 301 (19), rr. 1997-2004.
33. Saskia L.M.A. Beeres, Jeroen J. Bax, Dibbets P. et al. Atsma Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. J. Nucl. Med, 2006, vol. 47, no. 4, pp. 574-580.
34. Bukhovets I.L., Vorozhtsova I.N., Lavrov A.G. et al. Cellular cardiomyoplasty in the surgical treatment of patients with coronary heart disease and postinfarction cardiosclerosis: Results of the 3-year follow-up. Sibirskiy meditsinskiy zhurnal, 2011, vol. 26, no. 4, iss. 1 (in Russ.).